2Seventy Bio Valuation
| TSVT Stock | USD 3.99 0.03 0.76% |
At this time, the firm appears to be undervalued. 2Seventy Bio shows a prevailing Real Value of $7.04 per share. The current price of the firm is $3.99. Our model approximates the value of 2Seventy Bio from analyzing the firm fundamentals such as return on equity of -0.52, and Profit Margin of (2.07) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting 2Seventy Bio's valuation include:
Price Book 0.8956 | Enterprise Value 259.3 M | Enterprise Value Ebitda (1.29) | Price Sales 4.4781 | Enterprise Value Revenue 5.6847 |
Undervalued
Today
Please note that 2Seventy Bio's price fluctuation is slightly risky at this time. Calculation of the real value of 2Seventy Bio is based on 3 months time horizon. Increasing 2Seventy Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
2Seventy Bio's intrinsic value may or may not be the same as its current market price of 3.99, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.99 | Real 7.04 | Target 16.5 | Hype 4.01 |
The intrinsic value of 2Seventy Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence 2Seventy Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of 2Seventy Bio helps investors to forecast how 2Seventy stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 2Seventy Bio more accurately as focusing exclusively on 2Seventy Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use 2Seventy Bio's intrinsic value based on its ongoing forecasts of 2Seventy Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against 2Seventy Bio's closest peers.
2Seventy Bio Cash |
|
2Seventy Valuation Trend
2Seventy Bio's real value is important for investors to make better decisions and a more accurate overall view of 2Seventy Bio's financial worth over time. Using both 2Seventy Bio's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
2Seventy Bio Total Value Analysis
2Seventy Bio is at this time anticipated to have valuation of 259.34 M with market capitalization of 204.29 M, debt of 256.67 M, and cash on hands of 357.93 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the 2Seventy Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
259.34 M | 204.29 M | 256.67 M | 357.93 M |
2Seventy Bio Investor Information
About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 2Seventy Bio recorded a loss per share of 1.83. The entity had not issued any dividends in recent years. Based on the analysis of 2Seventy Bio's profitability, liquidity, and operating efficiency, 2Seventy Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.2Seventy Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. 2Seventy Bio has an asset utilization ratio of 17.75 percent. This implies that the Company is making $0.18 for each dollar of assets. An increasing asset utilization means that 2Seventy Bio is more efficient with each dollar of assets it utilizes for everyday operations.2Seventy Bio Ownership Allocation
2Seventy Bio holds a total of 51.59 Million outstanding shares. The majority of 2Seventy Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in 2Seventy Bio to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in 2Seventy Bio. Please pay attention to any change in the institutional holdings of 2Seventy Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.2Seventy Bio Profitability Analysis
The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M).About 2Seventy Bio Valuation
The stock valuation mechanism determines 2Seventy Bio's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of 2Seventy Bio based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of 2Seventy Bio. We calculate exposure to 2Seventy Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of 2Seventy Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 83.5 M | 98.7 M | |
| Pretax Profit Margin | (2.17) | (2.28) | |
| Operating Profit Margin | (2.16) | (2.27) | |
| Net Loss | (2.17) | (2.28) | |
| Gross Profit Margin | 0.83 | 0.96 |
2Seventy Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as 2Seventy Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 49.3 M |
2Seventy Bio Current Valuation Indicators
2Seventy Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final 2Seventy Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as 2Seventy Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use 2Seventy Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes 2Seventy Bio's worth.Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.